Advanced mobile surgical solutions to improve access to eye care for veterans, active duty and DoD personnel...
Use of the Chemo Mouthpiece resulted in a 46 per cent reduction in patient-reported oral pain symptoms compared to the control group...
Introducing the first scalable solution enabling real-time interventions for medication non-adherence...
This milestone acknowledges Triojection's potential to offer a highly effective, more accessible, and safer treatment for patients suffering from contained lumbar disc herniations...
Integration aims to enhance care coordination, transparency, and outcomes for musculoskeletal patients through EpicCare Link....
Bringing Clarity and Confidence to Ultrasound-Guided Interventional Procedures ...
Quarterly rehab program now welcomes Parkinson’s patients, offering intensive therapy with NeuFit’s NEUBIE device....
Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and incl...
Survey reveals tech adoption gap despite industry focus on trial efficiency ...
Targeting diverse diabetic population to enhance early detection of diabetic retinopathy ...
